Of 364 invasive carcinomas categorized into grades 1, 2 and 3, Estrogen Receptor positivity was noted in 77.3% (34/44), 60.8% (115/189) and 28.2% (37/131) respectively; Progesterone Receptor positivity was noted in 61.4% (27/44), 52.4% (99/189) and 21.4% (28/131) respectively; HER2/neu positivity was noted in 18.2% (8/44), 20.1% (38/189) and 19.8% (26/131) respectively. Triple negativity was found to be 9.1% (4/44), 21.7% (41/189) and 41.9% (55/131) in grade 1, 2 and 3 carcinomas respectively. Conclusions: Estrogen and Progesterone receptor expressing carcinomas were found to be more often of grade 1 category, with this rate declining through grades 2 and 3. No such correlation was noted for HER2/neu. Triple negative carcinomas were found to be of higher grade (grade 3).
INTRODUCTION
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death among females worldwide. 1 As per GLOBOCAN 2018 database, breast cancer ranks as the fifth leading cause of death (627000 deaths, 6.6%) and prognosis is considered to be relatively favourable in developed countries. 2 In Nepal, breast cancer accounts for 11.6% of all the cancer related deaths in women, ranking third after cervical and lung cancers. 3 
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All invasive breast carcinomas are routinely graded based on histological features, such as tubule/gland formation, nuclear pleomorphism and mitotic count. Significant association between histological grade and survival of patients has been demonstrated and it remains an independent prognostic factor for estrogen-receptor (ER) positive carcinomas. [4] [5] [6] Independent studies have highlighted negative relationship of ER/PR status with histological grade and similarly HER2/neu expression more in higher grade carcinomas. [7] [8] [9] [10] [11] [12] Assessment of hormone receptors and HER2/neu provides prognostic as well as predictive information on response to endocrine therapy and anti-HER2 targeted therapy respectively, and have become established procedures in routine management. 13 This study was carried out to analyze correlation of ER and Progesterone (PR) receptors, HER2/ neu status among different histological grades of invasive breast carcinomas.
MATERIALS AND METHODS
This is a retrospective study of cases received from January 2015 to December 2018 at Intrepid Cancer Diagnostics. All cases received between January 2015 to December 2018 for evaluation of ER, PR and HER2/neu status were included.
Formalin fixed paraffin embedded tissues were received. 4µm sections were cut and slides were stained with Hematoxylin & Eosin (H&E) for morphological evaluation. Sections were evaluated by two pathologists and morphological interpretation, histological typing was done based on World Health Organization classification of tumors of breast. 6 All cases of invasive carcinoma were histologically graded according to Elston-Ellis modification of the Scarff-Bloom-Richardson grading system (Nottingham grading system). 14, 15 Further sections were obtained on poly-L-lysine coated slides and processed for immunohistochemistry using Dako / Agilent antibodies with antigen-antibody streptavidin-Shrestha G et al.
biotin technique. Allred/Quick scoring system was used for interpretation of ER and PR. 6 ASCO/CAP guideline was used for assessment of HER2/neu overexpression pattern on immunohistochemistry. 16 Overall status of ER, PR, HER2/neu and triple negativity was analyzed among all cases of invasive breast carcinomas. Correlation between histological grade and immunohistochemical profile was evaluated on excisional biopsies and mastectomy specimens, that comprised 364 cases, while trucut biopsies, small biopsies, metastatic lesions were not included for this correlation. Statistical analysis was done using Statistical package for social sciences (SPSS) software, version 21. Chi-square test was used and P-value ≤0.01 was considered statistically significant.
RESULTS
Total 477 cases of invasive breast carcinoma were received between January 2015 to December 2018 for evaluation of ER, PR, HER2/neu status. Patients' age ranged from 22 to 91 years with mean age at diagnosis being 50 years and median age 48 years. 469 (98.3%) were female, while 8 (1.7%) were male. Slight predominance of left breast was noted (54.3% left, 45.7% right).
Distribution of hormone receptors and HER2/neu status among different histological types of invasive carcinoma and their overall status are shown in tables 1 and 2. Among 8 male patients (Table 3) , all 8 (100%) and 7 (87.5%) showed ER and PR positivity respectively. HER2/neu was uniformly negative and none showed triple negative status.
Out of 477 cases of invasive carcinomas, mastectomy and excisional biopsy specimens accounted for 364 cases and only these were included for statistical correlation between histological grade and ER, PR, HER2neu status. 
DISCUSSION
In present study, mean age of patients was 50 years with peak distribution among 45-55 years age group, comparable to other studies done within Nepal. 17, 18 Overall rate of ER/PR positivity (52%/43.8%) is similar to findings of Geethamala K (54%/52%), Dayal A (56.9%/35.5%) and Nepal B (46.9% / 48.9%) in studies conducted within Nepal as well as neighboring Asian countries. 7, 8, 19 Analysis of various other studies done within Nepal reveal ER/PR positivity status ranging from 20% to 48.9 percent. [17] [18] [19] [20] This finding, however, is different from studies done primarily in western, more developed regions, where positivity was found to be high, as much as 80%. 6, 21 Same holds true for PR, for which positivity was noted upto 70%. 6 The differing results raise the possibility of different genetic signature of breast cancers occurring among women of Asian population.
With respect to correlation of the histological grade with hormone receptors and HER2/neu status, most grade 1 carcinomas were ER/PR positive, while reverse held true for grade 3 carcinomas with p-value ≤0.01. Finding is in agreement with that elucidated by many other studies. 8, 9, 20, 22 This concurs with the accepted fact that ER, PR positive carcinomas tend to be of good prognosis and likewise, more of them would fall in grade 1 category.
No significant correlation was noted between HER2/neu and histological grade with 18.2%, 20.1% and 19.8% positivity in grade 1, 2 and 3 respectively, similar to studies conducted by Dayal A, Geethamala K and Emmanuel. 7, 8, 10 Findings appear to vary among studies, some exhibiting significant correlation. 11, 12 It does seem likely that carcinomas with HER2/neu positivity would cluster more in grade 3 category, considering HER2/neu positivity signify a poorer prognosis. It's apt to point out the limitation of this study with this regard, as fluorescence in situ hybridization (FISH) analysis for HER2/neu overexpression on indeterminate cases could not be done due to financial constraints and results could have varied if otherwise.
Triple negative breast cancers constituted 26.8% overall, with increasing trend from grade 1 through grade 3 invasive carcinomas (Table 4 ). Studies conducted within Nepal show triple negative cancers to range from 15.3% up to 41.3%. (17, 18, 20, 23, 24) Studies have shown that triple negative carcinomas vary with ethnicity and have documented a higher incidence in African women compared to Caucasians. 10, 12 
CONCLUSIONS
Immunohistochemical profile of different histological grades and types of invasive carcinomas in current study appear similar to those conducted in Indian subcontinent. However, studies from western, more developed regions show higher percentage of ER/PR positive carcinomas, indicating a possible differing gene signature of breast carcinomas occurring within Nepal and nearby Asian countries. Proper identification of HER2/neu overexpression by FISH is strongly recommended for all cases that show indeterminate IHC staining pattern. 
